Concurrent irinotecan and 5-fluorouracil plus levo-folinic acid given every other week in the first-line management of advanced colorectal carcinoma: A phase I study of the Southern Italy Cooperative Oncology Group-Reference-Cited by-同舟云学术

Concurrent irinotecan and 5-fluorouracil plus levo-folinic acid given every other week in the first-line management of advanced colorectal carcinoma: A phase I study of the Southern Italy Cooperative Oncology Group

Published:1999-08 Issue:8 Volume:10 Page:915-921
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Comella P.,Casaretti R.,De Vita F.,Avallone A.,Orditura M.,Petrillo A.,Gravina A.,Faranda A.,Comis S.,Comella G.,Catalano G.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/10/8/915/19477810/10-8-915.pdf

Reference29 articles.

1. Chemotherapy of gastrointestinal cancer;Moertel;N Engl J Med,1978

2. Modulation of fluorouracil by leucovorin in terms of response rate;J Clin Oncol,1992

3. DNA Topoisomerase I-targeted chemotherapy of human colon cancer in xenografts;Giovannella;Science,1989

4. Population pharmacokinetics and pharmacodynamics of irinotecan (CPT-11) and active metabolite SN-38 during phase 1 trials;Chabot;Ann Oncol,1995

5. Pharmacokinetics and pharmacodynamics of irinotecan during a phase II clinical trial in colorectal cancer;Canal;J Clin Oncol,1996

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular Markers for Colorectal Cancer;Surgical Clinics of North America;2017-06

2. A phase I, dose-finding study of irinotecan (CPT-11) short i.v. infusion combined with fixed dose of 5-fluorouracil (5-FU) protracted i.v. infusion in adult patients with advanced solid tumours;Cancer Chemotherapy and Pharmacology;2004-10-26

3. 5-Fluorouracil incorporation into RNA and DNA in relation to thymidylate synthase inhibition of human colorectal cancers;Annals of Oncology;2004-07

4. A Phase II Study with CPT-11 Plus Leucovorin and Bolus IV 5-Fluorouracil in Patients with Advanced Colorectal Carcinoma;Cancer Investigation;2003-01

5. Addition of either irinotecan or methotrexate to bolus5-fluorouracil and high-dose folinic acid every 2 weeks in advanced colorectal carcinoma: a randomised study by the Southern Italy Cooperative Oncology Group;Annals of Oncology;2002-06